liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
Publications (7 of 7) Show all publications
Isacson, S., Karlsson, K., Zalavary, S., Asratian, A., Örtegren Kugelberg, U., Liffner, S. & Öst, A. (2025). Small RNA in sperm–Paternal contributions to human embryo development. Nature Communications, 16(1), Article ID 6571.
Open this publication in new window or tab >>Small RNA in sperm–Paternal contributions to human embryo development
Show others...
2025 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 16, no 1, article id 6571Article in journal (Refereed) Published
Abstract [en]

Sperm not only delivers the paternal genome to the oocyte but also regulatory small RNA (sRNA). However, the role of sRNA in fertilisation and human embryo development remains poorly understood. Here, couples undergoing IVF are recruited, and sperm sRNA analysed to investigate their role in IVF treatment. Differential expression of mitochondrial sRNA and Y-RNA are observed in relation to sperm concentration. For fertilisation rate, sRNA from a single locus are significantly changed. Expression of microRNA (miRNA) and ribosomal sRNA correlates positively and negatively, respectively, to high-quality embryos. Notably, the top miRNA have an area under ROC of >0.8. Predicted targets of these miRNA are relevant for development, suggesting a role for sperm-borne miRNA in embryo development. In conclusion, sperm-borne sRNA are biomarkers for sperm concentration and embryo quality in IVF. These findings may contribute to clinical strategies improving embryo quality, lowering costs and reducing the need for additional treatment cycles.

Place, publisher, year, edition, pages
Springer Nature, 2025
National Category
Gynaecology, Obstetrics and Reproductive Medicine
Identifiers
urn:nbn:se:liu:diva-216218 (URN)10.1038/s41467-025-62015-2 (DOI)001530787700003 ()40670377 (PubMedID)2-s2.0-105010738291 (Scopus ID)
Note

Funding Agencies|Swedish Research Council [2015-03141, 2020-00577]; Ragnar Soderberg's foundation; Knut and Alice Wallenberg foundation [2015.0165]; ALF Grants Region Ostergoetland [ROE-995139, ROE-975378]; Vinnova [2020-00577] Funding Source: Vinnova; Swedish Research Council [2015-03141, 2020-00577] Funding Source: Swedish Research Council

Available from: 2025-08-06 Created: 2025-08-06 Last updated: 2025-09-01Bibliographically approved
Lundqvist, C., Asratian, A. & Wade, T. D. (2024). 563 EP098 – Untangling the relationships between age, gender, type of sport, perfectionistic self-presentation, and motivation on body satisfaction among female and male athletes aged 10–22. In: British Journal of Sports Medicine: . Paper presented at 7th IOC World Conference on Prevention of Injury and Illness in Sport, Monaco, 29; British Journal of Sports Medicine (pp. A120-A120). , 58(suppl 2)
Open this publication in new window or tab >>563 EP098 – Untangling the relationships between age, gender, type of sport, perfectionistic self-presentation, and motivation on body satisfaction among female and male athletes aged 10–22
2024 (English)In: British Journal of Sports Medicine, 2024, Vol. 58(suppl 2), p. A120-A120Conference paper, Poster (with or without abstract) (Other academic)
Abstract [en]

Background Body dissatisfaction is known as a robust predictor for eating pathology. Empirical knowledge about specific psychological mechanisms, beyond sports type, that can maintain or diminish female and male athletes’ body satisfaction is still sparse and research lack consistency. Prevention can decrease risk factors for eating pathology and protect athletes’ appreciation for the body and its functionality for continued and healthy sports participation.

Objective To explore the relationships between age, gender, type of sport, perfectionistic self-presentation, and motivation on body satisfaction among young athletes in one lean sport (gymnastics) and one non-lean sport (basketball). Hypotheses: Age, gender, and sport type are related to body satisfaction. A high autonomous motivation is positively related to body satisfaction while perfectionistic self-presentation displays a negative relationship.

Design Cross-sectional.

Setting Recreational to national elite level.

Participants A total of 209 athletes (basketball players n=77; gymnasts n=132; age range: 10–22) were recruited and 200 (females: n=157; males: n=43) were included in the analyses after data screening.

Assessment of Risk Factors Questionnaires were completed electronically and assessed demographic information (e.g., age, self-assigned gender), motivation (Behavioral Regulation in Sport Questionnaire), perfectionistic self-presentation (Perfectionistic Self-Presentation Scale – Junior Form) and body satisfaction (Body Appreciation Scale-2).

Main Outcome Measurements Body satisfaction (dependent variable).

Results Stepwise multiple regressions with bootstrapping showed age, self-assigned gender, and perfectionistic self-presentation (non-display of imperfection) to significantly predict body satisfaction (p<.05). Path analysis showed a significant relationship between age and body satisfaction (standardized coefficient: -.23) which was partially mediated by non-display of imperfection (p<.05). A moderated mediation analysis showed that this relationship was not moderated by gender.

Conclusions Body satisfaction prevention should target perfectionistic self-presentation tendencies among female and male athletes. Further research is warranted to investigate if non-display of imperfection is a prominent perfectionistic self-presentation facet among athletes across gender, sports and competition levels.

National Category
Social Sciences Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-204007 (URN)10.1136/bjsports-2024-IOC.213 (DOI)
Conference
7th IOC World Conference on Prevention of Injury and Illness in Sport, Monaco, 29; British Journal of Sports Medicine
Available from: 2024-05-31 Created: 2024-05-31 Last updated: 2024-06-05Bibliographically approved
Pietrzak, M., Yngve, A., Hamilton, P. J., Asratian, A., Gauffin, E., Löfberg, A., . . . Böhme, R. (2024). Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial. Neuropsychopharmacology, 49, 1042-1049
Open this publication in new window or tab >>Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial
Show others...
2024 (English)In: Neuropsychopharmacology, ISSN 0893-133X, E-ISSN 1740-634X, Vol. 49, p. 1042-1049Article in journal (Refereed) Published
Abstract [en]

The stomach-derived hormone ghrelin plays not only a role in feeding, starvation, and survival, but it has been suggested to also be involved in the stress response, in neuropsychiatric conditions, and in alcohol and drug use disorders. Mechanisms related to reward processing might mediate ghrelin's broader effects on complex behaviors, as indicated by animal studies and mostly correlative human studies. Here, using a within-subject double-blind placebo-controlled design with intravenous ghrelin infusion in healthy volunteers (n = 30), we tested whether ghrelin alters sensitivity to reward and punishment in a reward learning task. Parameters were derived from a computational model of participants' task behavior. The reversal learning task with monetary rewards was performed during functional brain imaging to investigate ghrelin effects on brain signals related to reward prediction errors. Compared to placebo, ghrelin decreased punishment sensitivity (t = -2.448, p = 0.021), while reward sensitivity was unaltered (t = 0.8, p = 0.43). We furthermore found increased prediction-error related activity in the dorsal striatum during ghrelin administration (region of interest analysis: t-values >= 4.21, p-values <= 0.044). Our results support a role for ghrelin in reward processing that extends beyond food-related rewards. Reduced sensitivity to negative outcomes and increased processing of prediction errors may be beneficial for food foraging when hungry but could also relate to increased risk taking and impulsivity in the broader context of addictive behaviors.

Place, publisher, year, edition, pages
Springer Science+Business Media B.V., 2024
National Category
Psychiatry Neurosciences Economics
Identifiers
urn:nbn:se:liu:diva-202021 (URN)10.1038/s41386-024-01821-6 (DOI)001172407400001 ()38409282 (PubMedID)2-s2.0-85186205980 (Scopus ID)
Funder
Marcus Wallenbergs Foundation for International Scientific Collaboration, 2014.0187Swedish Research Council, 2013-07434
Note

Funding Agencies|Swedish Research Council [2013-07434]; Marcus and Marianne Wallenberg foundation [2014.0187]; NIH IRP (NIDA); NIH IRP (NIAAA); Linkoeping University

Available from: 2024-04-04 Created: 2024-04-04 Last updated: 2025-08-11
Lundqvist, C., Kolbeinsson, Ö., Asratian, A. & Wade, T. D. (2024). Untangling the relationships between age, gender, type of sport, perfectionistic self-presentation, and motivation on body satisfaction.: A cross-sectional study on aesthetic and non-aesthetic female and male athletes aged 10 to 22.. BMJ Open Sport & Exercise Medicine, 10(3), Article ID e001975.
Open this publication in new window or tab >>Untangling the relationships between age, gender, type of sport, perfectionistic self-presentation, and motivation on body satisfaction.: A cross-sectional study on aesthetic and non-aesthetic female and male athletes aged 10 to 22.
2024 (English)In: BMJ Open Sport & Exercise Medicine, E-ISSN 2055-7647, Vol. 10, no 3, article id e001975Article in journal (Refereed) Published
Abstract [en]

Objectives: To explore the relationships between age, gender, type of sport, perfectionistic self-presentation and motivation on body satisfaction among young athletes in one aesthetic sport (gymnastics) and one non-aesthetic sport (basketball). The study hypothesise that (1) age, gender, and type of sport (aesthetic or non-aesthetic) will predict body satisfaction scores, (2) autonomous motivation will positively relate to body satisfaction, and (3) perfectionistic self-presentation will negatively relate to body satisfaction.

Design: Cross-sectional. 

Method: 209 athletes (132 gymnasts and 77 basketball players) aged 10-22 (median=13 years) were recruited. After data screening, 200 athletes were included in analyses (females: n=155; males: n=45). Participants completed an online survey which assessed demographic information, athlete motivation (Behavioral Regulation in Sport Questionnaire), perfectionistic self-presentation (Perfectionistic Self-Presentation Scale – Junior Form) and body satisfaction (Body Appreciation Scale-2). 

Results: Hierarchical multiple regression showed age, self-assigned gender, and two facets of perfectionism (perfectionistic self-presentation and non-disclosure of imperfection) to predict reported levels of body satisfaction significantly. Subsequently, adding motivational variables did not improve the model. A moderation analysis showed that the relationship between non-disclosure of imperfection and body satisfaction was significantly moderated by gender. 

Conclusions: Two facets of perfectionism were associated with reported body satisfaction. Additionally, the relationship between non-disclosure of imperfection and body satisfaction appears to differ between female and male athletes. Researchers should move beyond sport types and identify factors (e.g., perfectionistic self-presentation) at the individual and environmental level that can protect young athletes’ body satisfaction.

Place, publisher, year, edition, pages
BMJ PUBLISHING GROUP, 2024
Keywords
adolescent, athlete, body image, eating disorder, psychology
National Category
Sport and Fitness Sciences
Identifiers
urn:nbn:se:liu:diva-205766 (URN)10.1136/bmjsem-2024-001975 (DOI)001259862500001 ()38962362 (PubMedID)
Available from: 2024-07-02 Created: 2024-07-02 Last updated: 2025-08-28
Perini, I., Mayo, L. M., Johansson Capusan, A., Paul, E., Yngve, A., Kämpe, R., . . . Heilig, M. (2023). Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation. Molecular Psychiatry (6), 2563-2571
Open this publication in new window or tab >>Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation
Show others...
2023 (English)In: Molecular Psychiatry, ISSN 1359-4184, E-ISSN 1476-5578, no 6, p. 2563-2571Article in journal (Refereed) Published
Abstract [en]

Childhood maltreatment (CM) is a risk factor for substance use disorders (SUD) in adulthood. Understanding the mechanisms by which people are susceptible or resilient to developing SUD after exposure to CM is important for improving intervention. This case-control study investigated the impact of prospectively assessed CM on biomarkers of endocannabinoid function and emotion regulation in relation to the susceptibility or resilience to developing SUD. Four groups were defined across the dimensions of CM and lifetime SUD (N = 101 in total). After screening, participants completed two experimental sessions on separate days, aimed at assessing the behavioral, physiological, and neural mechanisms involved in emotion regulation. In the first session, participants engaged in tasks assessing biochemical (i.e., cortisol, endocannabinoids), behavioral, and psychophysiological indices of stress and affective reactivity. During the second session, the behavioral and brain mechanisms associated with emotion regulation and negative affect were investigated using magnetic resonance imaging. CM-exposed adults who did not develop SUD, operationally defined as resilient to developing SUD, had higher peripheral levels of the endocannabinoid anandamide at baseline and during stress exposure, compared to controls. Similarly, this group had increased activity in salience and emotion regulation regions in task-based measures of emotion regulation compared to controls, and CM-exposed adults with lifetime SUD. At rest, the resilient group also showed significantly greater negative connectivity between ventromedial prefrontal cortex and anterior insula compared to controls and CM-exposed adults with lifetime SUD. Collectively, these peripheral and central findings point to mechanisms of potential resilience to developing SUD after documented CM exposure.

Place, publisher, year, edition, pages
SPRINGERNATURE, 2023
National Category
Psychiatry
Identifiers
urn:nbn:se:liu:diva-193375 (URN)10.1038/s41380-023-02033-y (DOI)000967871600001 ()37041416 (PubMedID)
Note

Funding Agencies|Swedish Research Council for Infrastructures and Science for Life Laboratory, Sweden; Swedish Research Council [2013-07434]; Medical Training and Research Agreement in Ostergotland Region [ALF 2017: LIO-599451, ALF 2018: LIO-692621, ALF 2019: LIO-791581, ALF 2020: RO-888021, ALF 2021: RO-935602]; Systembolagets alkoholforskningsrad [2016-0018, 2017-0075, 2018-0030, 2019-0007]; Brain & Behavior Research Foundation NARSAD Young Investigator Grant [27094]

Available from: 2023-05-03 Created: 2023-05-03 Last updated: 2024-05-02Bibliographically approved
Paul, E., Schwieler, L., Erhardt, S., Boda, S., Trepci, A., Kämpe, R., . . . Samuelsson, M. (2022). Peripheral and central kynurenine pathway abnormalities in major depression. Brain, behavior, and immunity, 101, 136-145
Open this publication in new window or tab >>Peripheral and central kynurenine pathway abnormalities in major depression
Show others...
2022 (English)In: Brain, behavior, and immunity, ISSN 0889-1591, E-ISSN 1090-2139, Vol. 101, p. 136-145Article in journal (Refereed) Published
Abstract [en]

Considerable data relate major depressive disorder (MDD) with aberrant immune system functioning. Pro inflammatory cytokines facilitate metabolism of tryptophan along the kynurenine pathway (KP) putatively resulting in reduced neuroprotective and increased neurotoxic KP metabolites in MDD, in addition to modulating metabolic and immune function. This central nervous system hypothesis has, however, only been tested in the periphery. Here, we measured KP-metabolite levels in both plasma and cerebrospinal fluid (CSF) of depressed patients (n = 63/36 respectively) and healthy controls (n = 48/33). Further, we assessed the relation between KP abnormalities and brain-structure volumes, as well as body mass index (BMI), an index of metabolic disturbance associated with atypical depression. Plasma levels of picolinic acid (PIC), the kynurenic/quinolinic acid ratio (KYNA/QUIN), and PIC/QUIN were lower in MDD, but QUIN levels were increased. In the CSF, we found lower PIC in MDD. Confirming previous work, MDD patients had lower hippocampal, and amygdalar volumes. Hippocampal and amygdalar volumes were correlated positively with plasma KYNA/QUIN ratio in MDD patients. BMI was increased in the MDD group relative to the control group. Moreover, BMI was inversely correlated with plasma and CSF PIC and PIC/QUIN, and positively correlated with plasma QUIN levels in MDD. Our results partially confirm previous peripheral KP findings and extend them to the CSF in MDD. We present the novel finding that abnormalities in KP metabolites are related to metabolic disturbances in depression, but the relation between KP metabolites and depression-associated brain atrophy might not be as direct as previously hypothesized.

Place, publisher, year, edition, pages
Academic Press Inc - Elsevier Science, 2022
Keywords
Major depressive disorder; Kynurenine pathway; Inflammation; Central nervous system; Brain volumetry; Structural magnetic resonance imaging; Cerebrospinal fluid
National Category
Neurology
Identifiers
urn:nbn:se:liu:diva-183765 (URN)10.1016/j.bbi.2022.01.002 (DOI)000761260700005 ()34999196 (PubMedID)
Note

Funding Agencies|Johnson & Johnson Innovation; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2017-00875, 2013-07434, 2019-01138]; ALF Grants, Region Ostergotland; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 CA193522, R01 NS073939]; MD Anderson Cancer Support Grant [P30 CA016672]

Available from: 2022-03-24 Created: 2022-03-24 Last updated: 2023-10-13
Mayo, L. M., Asratian, A., Lindé, J., Holm, L., Nätt, D., Augier, G., . . . Heilig, M. (2020). Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice. Molecular Psychiatry, 25(5), 993-1005
Open this publication in new window or tab >>Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice
Show others...
2020 (English)In: Molecular Psychiatry, ISSN 1359-4184, E-ISSN 1476-5578, Vol. 25, no 5, p. 993-1005Article in journal (Refereed) Published
Abstract [en]

Post-traumatic stress disorder (PTSD) is a common, debilitating condition with limited treatment options. Extinction of fear memories through prolonged exposure therapy, the primary evidence-based behavioral treatment for PTSD, has only partial efficacy. In mice, pharmacological inhibition of fatty acid amide hydrolase (FAAH) produces elevated levels of anandamide (AEA) and promotes fear extinction, suggesting that FAAH inhibitors may aid fear extinction-based treatments. A human FAAH 385C-greater thanA substitution encodes an FAAH enzyme with reduced catabolic efficacy. Individuals homozygous for the FAAH 385A allele may therefore offer a genetic model to evaluate the impact of elevations in AEA signaling in humans, helping to inform whether FAAH inhibitors have the potential to facilitate fear extinction therapy for PTSD. To overcome the challenge posed by low frequency of the AA genotype (appr. 5%), we prospectively genotyped 423 individuals to examine the balanced groups of CC, AC, and AA individuals (n = 25/group). Consistent with its loss-of-function nature, the A allele was dose dependently associated with elevated basal AEA levels, facilitated fear extinction, and enhanced the extinction recall. Moreover, the A-allele homozygotes were protected against stress-induced decreases in AEA and negative emotional consequences of stress. In a humanized mouse model, AA homozygous mice were similarly protected against stress-induced decreases in AEA, both in the periphery, and also in the amygdala and prefrontal cortex, brain structures critically involved in fear extinction and regulation of stress responses. Collectively, these data suggest that AEA signaling can temper aspects of the stress response and that FAAH inhibition may aid the treatment for stress-related psychiatric disorders, such as PTSD.

Place, publisher, year, edition, pages
Nature Publishing Group, 2020
National Category
Neurosciences
Identifiers
urn:nbn:se:liu:diva-154914 (URN)10.1038/s41380-018-0215-1 (DOI)000529878300007 ()30120421 (PubMedID)2-s2.0-85052287102 (Scopus ID)
Note

Funding agencies: Swedish Research CouncilSwedish Research Council [2013-7434]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Alberta Innovates and BranchOut Neurological Foundation

Available from: 2019-03-05 Created: 2019-03-05 Last updated: 2021-05-07Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-7696-0508

Search in DiVA

Show all publications